BlackRock Advisors’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

BlackRock Advisors’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7K	Hold	9	–	–	﹤0.01%	3608
2016 Q3	$9K	Hold	9	–	–	﹤0.01%	3592
2016 Q2	$13K	Hold	9	–	–	﹤0.01%	3540
2016 Q1	$12K	Hold	9	–	–	﹤0.01%	3552
2015 Q4	$12K	Hold	9	–	–	﹤0.01%	3606
2015 Q3	$14K	Hold	9	–	–	﹤0.01%	3597
2015 Q2	$21K	Hold	9	–	–	﹤0.01%	3502
2015 Q1	$28K	Hold	9	–	–	﹤0.01%	3385
2014 Q4	$31K	Hold	9	–	–	﹤0.01%	3392
2014 Q3	$33K	Hold	9	–	–	﹤0.01%	3377
2014 Q2	$36K	Sell	9 -11	-55%	-$41.4K	﹤0.01%	3317
2014 Q1	$81K	Buy	20 +1	+5%	+$4.46K	﹤0.01%	3119
2013 Q4	$70K	Buy	19 +3	+19%	+$11.4K	﹤0.01%	3169
2013 Q3	$62K	Buy	16 +1	+7%	+$7.5K	﹤0.01%	3136
2013 Q2	$145K	Buy	+15	New	+$166K	﹤0.01%	2662

Other funds holding FRTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BlackRock Advisors's FRTX Position: Q4 2016 in Review

BlackRock Advisors held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q4 2016 at 9 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #3608.

BlackRock Advisors first reported a position in FRTX in Q2 2013 and has held it in 15 quarters since. The position peaked at $145K in Q2 2013. 26 funds tracked by Wall St. Rank hold FRTX as of Q4 2016.

BlackRock Advisors held 9 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $7K as of Q4 2016.
BlackRock Advisors left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q4 2016.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3608 holding.
BlackRock Advisors first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Advisors's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $145K in Q2 2013.
26 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.